Exec Chat: PFA, Patient Monitoring, Modular CRM Open Opportunities For Boston Scientific
Executive Summary
In an interview with Medtech Insight, Angelo De Rosa, the general manager of Boston Scientific’s cardiac rhythm management and electrophysiology businesses in Europe, Middle East and Africa (EMEA), discussed some of his company’s recent achievements and the opportunities it is addressing in 2022.
You may also be interested in...
Cardio Catch-Up: Arga, HeartPoint Plan First-In-Human Trials Of Novel Devices; Medtronic And Edwards Announce Product Launches, And More
The second half of summer is usually a slow time for news about cardiac technology innovations because there are not many major conferences. But there was still plenty of innovation news coming from both small and big cardiovascular device companies in July and August.
Acutus Names David Roman As New CEO; Mickelsen Departs Company
After announcing that its estimated second-quarter 2022 revenue exceeded analysts’ expectations, Acutus announced that David Roman, the interim CEO and CFO, is now the permanent CEO. Also, Steven Mickelsen announced that he is stepping down as Acutus’ chief translational science officer.
Boston Scientific Brings Remote Clinical Support To Europe, Africa And Middle East
Telefónica España subsidiary TedCas signed a deal with Boston Scientific to provide telecommunications technology to Boston Scientific’s new Remote Clinical Support Centre (RhythmCare) in Madrid and provide remote support to hospitals in Europe, Africa and the Middle East.